• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
ZHOU Weili,ZHAO Yanxia,SUN Tong,WANG Kun,HUA Fengbiao,ZONG Fengyu,CHENG Chunlei.Situation analysis of drug quality risk monitoring working mechanism construction[J].Journal Of Pharmaceutical Research,2022,41(11):767-770[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2259times   Download 2088次 QR Code for this article
Scan with your phone!
药品质量风险监测工作机制建设态势分析
周维利1,赵艳霞1,孙铜1,王坤1,华逢彪1,宗凤玉2,程春雷1
Font:Larger+|Default|Smaller-
(1.山东省食品药品检验研究院,山东 济南 250101;2.山东省药品监督管理局,山东 济南 250014)
摘要:
目的 分析山东省药品质量风险监测工作建设面临的态势,为进一步提高药品质量管理水平提供参考。方法 梳理分析我省药品质量风险监测工作情况及采取的措施,参考道斯矩阵(SWOT)进行分析药品质量风险监测工作机制建设的优势、劣势、机会和挑战。结果与结论 药品质量风险监测工作,作为常规抽检的重要补充,发挥了药品监督及服务企业的作用,同时面临着内部和外部的有利与不利因素,建议充分利用网络智慧监管、优化抽检工作安排、加强业务培训、培养专家队伍、完善信息公开、注重日常监管,对药品质量风险监测工作机制不断完善,全面提升药品监管效能。
关键词:  药品质量  风险监测  工作机制建设  道斯矩阵
DOI:10.13506/j.cnki.jpr.2022.11.016
基金项目:
Publication Date:November 25, 2022
Situation analysis of drug quality risk monitoring working mechanism construction
ZHOU Weili1,ZHAO Yanxia1,SUN Tong1,WANG Kun1,HUA Fengbiao1,ZONG Fengyu2,CHENG Chunlei1
(1.Shandong Institute of Food and Drug Control, Jinan 250101, China;2.Shandong Provincial Drug Administration, Jinan 250014, China)
Abstract:
Objective The situation of drug quality risk monitoring in Shandong province was analyzed to provide reference for further improving drug quality management. Methods The work situation and measures of drug quality risk monitoring in Our province were analyzed, and the advantages, disadvantages, opportunities and challenges of the work mechanism construction of drug quality risk monitoring were analyzed by referring to SWOT. Results and Conclusion Risk of drug quality monitoring work, as the important supplement of the conventional sampling inspection, give play to the role of the drug supervision and service enterprises, at the same time facing the favorable and unfavorable factors, the internal and external advice make full use of network intelligent supervision, optimizing the sampling work arrangements, strengthen business training, training expertise, perfecting the information disclosure, and pay attention to daily regulation, We will constantly improve the working mechanism of drug quality risk monitoring, and comprehensively improve the effectiveness of drug supervision.
Key words:  Quality of medicine  Risk monitoring  Working mechanism construction  SWOT
Today's Visits:492    Total Visits:2383211
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.